ZYNERBA PHARMACEUTICALS, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
ZYNERBA PHARMACEUTICALS, INC. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$20.89 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2023-08-14
- ZYNERBA PHARMACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2023-06-30 was -$10.78M.
- ZYNERBA PHARMACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2023-03-31 was -$10.11M.
- ZYNERBA PHARMACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-12-31 was -$8.02M.
- ZYNERBA PHARMACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-09-30 was -$8.68M.
- ZYNERBA PHARMACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$35.04M.
- ZYNERBA PHARMACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was -$37.31M.
- ZYNERBA PHARMACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2020 was -$51.34M.
- ZYNERBA PHARMACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2019 was -$32.94M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2023-06-30 | -$10.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$20.89M 10-Q · filed 2023-08-14 | -$28.91M derived: sum of 3 quarters · filed 2023-08-14 | -$37.58M derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | -$10.11M 10-Q · filed 2023-05-15 | -$18.13M derived: sum of 2 quarters · filed 2023-05-15 | -$26.81M derived: sum of 3 quarters · filed 2023-05-15 | -$36.66M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-12-31 | -$8.02M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$16.69M derived: sum of 2 quarters · filed 2023-03-28 | -$26.55M derived: sum of 3 quarters · filed 2023-08-14 | -$35.04M 10-K · filed 2023-03-28 |
| 2022-09-30 | -$8.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$18.53M derived: sum of 2 quarters · filed 2023-08-14 | -$27.02M 10-Q · filed 2022-11-14 | -$35.83M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-06-30 | -$9.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$18.34M 10-Q · filed 2023-08-14 | -$27.16M derived: sum of 3 quarters · filed 2023-08-14 | -$37.74M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$8.49M 10-Q · filed 2023-05-15 | -$17.31M derived: sum of 2 quarters · filed 2023-05-15 | -$27.89M derived: sum of 3 quarters · filed 2023-05-15 | -$37.84M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$8.82M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$19.40M derived: sum of 2 quarters · filed 2023-03-28 | -$29.35M derived: sum of 3 quarters · filed 2023-03-28 | -$37.31M 10-K · filed 2023-03-28 |
| 2021-09-30 | -$10.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$20.53M derived: sum of 2 quarters · filed 2022-11-14 | -$28.49M 10-Q · filed 2022-11-14 | -$38.11M derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-06-30 | -$9.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$17.91M 10-Q · filed 2022-08-10 | -$27.53M derived: sum of 3 quarters · filed 2023-03-28 | -$36.58M derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-03-31 | -$7.96M 10-Q · filed 2022-05-16 | -$17.58M derived: sum of 2 quarters · filed 2023-03-28 | -$26.63M derived: sum of 3 quarters · filed 2023-03-28 | -$46.96M derived: sum of 4 quarters · filed 2023-03-28 |
| 2020-12-31 | -$9.62M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$18.67M derived: sum of 2 quarters · filed 2023-03-28 | -$39.00M derived: sum of 3 quarters · filed 2023-03-28 | -$51.34M 10-K · filed 2023-03-28 |
| 2020-09-30 | -$9.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$29.38M derived: sum of 2 quarters · filed 2021-11-15 | -$41.72M 10-Q · filed 2021-11-15 | -$52.43M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$20.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$32.67M 10-Q · filed 2021-08-09 | -$43.39M derived: sum of 3 quarters · filed 2022-03-01 | -$45.33M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$12.34M 10-Q · filed 2021-05-12 | -$23.05M derived: sum of 2 quarters · filed 2022-03-01 | -$25.00M derived: sum of 3 quarters · filed 2022-03-01 | -$36.13M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$10.71M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$12.66M derived: sum of 2 quarters · filed 2022-03-01 | -$23.80M derived: sum of 3 quarters · filed 2022-03-01 | -$32.94M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$13.08M derived: sum of 2 quarters · filed 2020-11-09 | -$22.23M 10-Q · filed 2020-11-09 | -$30.02M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-06-30 | -$11.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$20.28M 10-Q · filed 2020-08-10 | -$28.07M derived: sum of 3 quarters · filed 2021-03-10 | -$35.88M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-03-31 | -$9.15M 10-Q · filed 2020-05-11 | -$16.94M derived: sum of 2 quarters · filed 2021-03-10 | -$24.74M derived: sum of 3 quarters · filed 2021-03-10 | -$36.75M derived: sum of 4 quarters · filed 2021-03-10 |
| 2018-12-31 | -$7.79M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | -$15.60M derived: sum of 2 quarters · filed 2021-03-10 | -$27.60M derived: sum of 3 quarters · filed 2021-03-10 | -$39.91M 10-K · filed 2021-03-10 |
| 2018-09-30 | -$7.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$19.81M derived: sum of 2 quarters · filed 2019-11-06 | -$32.12M 10-Q · filed 2019-11-06 | -$40.24M derived: sum of 4 quarters · filed 2020-03-10 |
| 2018-06-30 | -$12.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$24.31M 10-Q · filed 2019-08-06 | -$32.43M derived: sum of 3 quarters · filed 2020-03-10 | -$40.74M derived: sum of 4 quarters · filed 2020-03-10 |
| 2018-03-31 | -$12.31M 10-Q · filed 2019-05-08 | -$20.42M derived: sum of 2 quarters · filed 2020-03-10 | -$28.74M derived: sum of 3 quarters · filed 2020-03-10 | -$37.06M derived: sum of 4 quarters · filed 2020-03-10 |
| 2017-12-31 | -$8.12M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | -$16.43M derived: sum of 2 quarters · filed 2020-03-10 | -$24.75M derived: sum of 3 quarters · filed 2020-03-10 | -$32.01M 10-K · filed 2020-03-10 |
| 2017-09-30 | -$8.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$16.63M derived: sum of 2 quarters · filed 2018-11-08 | -$23.89M 10-Q · filed 2018-11-08 | -$30.79M derived: sum of 4 quarters · filed 2019-03-11 |
| 2017-06-30 | -$8.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$15.58M 10-Q · filed 2018-08-02 | -$22.48M derived: sum of 3 quarters · filed 2019-03-11 | -$28.46M derived: sum of 4 quarters · filed 2019-03-11 |
| 2017-03-31 | -$7.26M 10-Q · filed 2018-05-08 | -$14.16M derived: sum of 2 quarters · filed 2019-03-11 | -$20.14M derived: sum of 3 quarters · filed 2019-03-11 | |
| 2016-12-31 | -$6.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | -$12.88M derived: sum of 2 quarters · filed 2019-03-11 | -$23.39M 10-K · filed 2019-03-11 | |
| 2016-09-30 | -$5.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$16.49M 10-Q · filed 2017-11-14 | ||
| 2016-06-30 | -$10.51M 10-Q · filed 2017-08-01 | |||
| 2015-12-31 | -$12.55M 10-K · filed 2018-03-12 |